Brought to you by 
Kyowa Hakko to pay £292mm for spec pharma ProStrakan
Mar 2011
Executive Summary
Kirin Holdings Co. Ltd.’s pharma group Kyowa Hakko Kirin Co. Ltd. is attempting to acquire public Scottish company ProStrakan Group PLC for £292mm ($473mm) in cash. Kyowa will pay £1.30 per share, a 31% premium to the ten-day average prior to November 12, 2010, when ProStrakan began its offer period. ProStrakan said it had received bids from several suitors over the past few months, including an unsolicited £1-per-share offer from Norgine.
Deal Industry
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Payment Includes Cash
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com